Company / Net Income
Annovis Bio, Inc. Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$28.9M
FY2025
5-year range
-$56.2M / -$5.5M
FY2021-FY2025
Trend
+48.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$25M to -$29M over the past 2 years.
Based on SEC 10-K filings.
-$29M in FY2025.
Declined from -$25M to -$29M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 48.7% year-over-year.
- Peak net income was recorded in FY2020.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$28.9M | +48.7% |
| FY2024 | -$56.2M | -121.9% |
| FY2023 | -$25.3M | +0.0% |
| FY2022 | -$25.3M | -363.7% |
| FY2021 | -$5.5M | -451.2% |
| FY2020 | -$991.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026